Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.
More news about People's Republic of China
- US judge blocks release of alleged Beijing agent accused of filming Taiwan leader’s sonA federal judge on Wednesday ordered Wanying “Heather” Zhang be held in custody, after her lawyers – who had fought to keep her out of jail – said she “looks forward to establishing” her innocence...
- Šefčovič goes to Beijing with a final plea to avoid an EU-China trade warAlso in this newsletter: Burnham travels to Berlin to win EU friends
- EU’s top trade envoy in China for tense talks over carsBrussels blames Beijing’s surging exports for the loss of tens of thousands of manufacturing jobs
- Author Daniel Bell Applies Confucian Thinking to Chinese Invasion of Taiwan at Belfer Center Talk - The Harvard CrimsonAuthor Daniel Bell Applies Confucian Thinking to Chinese Invasion of Taiwan at Belfer Center Talk The Harvard Crimson
- How China’s 25 Trillion-Yuan Infrastructure Plan Could Offset WeaknessesBofA Global Research Chief Greater China Economist Helen Qiao estimates China's 25 trillion-yuan infrastructure investment plan could generate 5 trillion yuan of economic activity annually, helping...
- As China and the EU begin crunch trade talks, optimism is in short supplyAs China and the European Union began a fresh round of trade talks in Beijing on Thursday, observers on both sides appeared to agree on one thing: a big breakthrough was unlikely. Chinese firms bas...
- US bars Fiji-based man over corruption tied to China - Al JazeeraUS bars Fiji-based man over corruption tied to China Al Jazeera
- US bars Fiji-based man over corruption tied to ChinaThe State Department has accused the man of paying bribes to Fijian citizens to advance Chinese interests.